日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

IL21-STAT3 controls the pentose phosphate pathway to support metabolic reprogramming and tumor progression in chronic lymphocytic leukemia.

IL21-STAT3 控制磷酸戊糖途径,以支持慢性淋巴细胞白血病中的代谢重编程和肿瘤进展。

Del Prete Rosita, Tusha Vjola, Simon-Molas Helga, Gazziero Virginia Anna, Nardi Federica, Drago Roberta, Bartolini Gaia, Licastro Danilo, Malchiodi Margherita, Mariottini Cristina, Marotta Giuseppe, Caravagna Giulio, Bruscoli Stefano, Eldering Eric, Gozzetti Alessandro, Bocchia Monica, Kabanova Anna

Price transparency of cancer medicines: a crucial step towards informed pricing negotiations in the European region

癌症药物价格透明度:迈向欧洲地区知情定价谈判的关键一步

Vancoppenolle, Julie; Franzen, Nora; Andrianò, Cristina; Houlind, Morten Baltzer; Ćetković, Zora; Dane, Aniek; Degrassat-Théas, Albane; Eldering-Heldens, Anne M P; Hug, Martin J; Knoth, Holger; Ladisa, Vito; Vajda, Péter; Warnke, Ulrich; Retèl, Valesca; van Harten, Wim H

Cholesterol homeostasis and lipid raft dynamics at the basis of tumor-induced immune dysfunction in chronic lymphocytic leukemia.

胆固醇稳态和脂筏动力学是慢性淋巴细胞白血病肿瘤诱导免疫功能障碍的基础

Jacobs Chaja F, Peters Fleur S, Camerini Elena, Cretenet Gaspard, Rietveld Joanne, Schomakers Bauke V, van Weeghel Michel, Hahn Nico, Verberk Sanne G S, Van den Bossche Jan, Langeveld Mirjam, Kleijwegt Fleur, Eldering Eric, Zelcer Noam, Kater Arnon P, Simon-Molas Helga

Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL

纵向组学数据和临床前治疗表明,蛋白酶体抑制剂卡非佐米可作为伊布替尼耐药性慢性淋巴细胞白血病(CLL)的治疗方法。

Arseni, Lavinia; Sigismondo, Gianluca; Yazdanparast, Haniyeh; Hermansen, Johanne U; Mack, Norman; Ohl, Sibylle; Kalter, Verena; Iskar, Murat; Kalxdorf, Mathias; Friedel, Dennis; Rettel, Mandy; Paul, Yashna; Ringshausen, Ingo; Eldering, Eric; Dubois, Julie; Kater, Arnon P; Zapatka, Marc; Roessner, Philipp M; Tausch, Eugen; Stilgenbauer, Stephan; Dietrich, Sascha; Savitski, Mikhail M; Skånland, Sigrid S; Krijgsveld, Jeroen; Lichter, Peter; Seiffert, Martina

Disruption of constitutive CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasms.

CXCR4 寡聚体的组成破坏会损害淋巴瘤的致癌特性

Mobach Simon, Bergkamp Nick D, Ma Ziliang, Haselager Marco V, Anbuhl Stephanie M, Jurriens Daphne, van den Bor Jelle, Wang Ziming, Crudden Caitrin, Roos Jamie L, Perez Almeria Claudia V, Boergonje Rick A, Lohse Martin J, Bosma Reggie, Eldering Eric, Siderius Marco, Wu Wei, Spaargaren Marcel, Tonino Sanne H, Kater Arnon P, Smit Martine J, Heukers Raimond

CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axis

CD40L 和 IL-4 通过 HLA-E:NKG2A 轴抑制 NK 细胞介导的抗体依赖性细胞毒性作用。

Graham, Lara V; Horehajova, Ludmila; Haselager, Marco V; Fisher, Jack G; Roos, Jamie Lee; Foxall, Russell B; John, Mel; Cox, Kerry L; Oldham, Robert J; Taylor, Martin C; Ashton-Key, Margaret; Sale, Ben; Bartlett, Laura G; Roghanian, Ali; Eldering, Eric; Vallejo, Andres F; Forconi, Francesco; Khakoo, Salim I; Cragg, Mark S; Blunt, Matthew D

Electron transport chain and mTOR inhibition synergistically decrease CD40 signaling and counteract venetoclax resistance in chronic lymphocytic leukemia

电子传递链和 mTOR 抑制协同降低 CD40 信号传导,并对抗慢性淋巴细胞白血病中的维奈托克耐药性。

Chen, Zhenghao; Cretenet, Gaspard; Carnazzo, Valeria; Simon-Molas, Helga; Kater, Arnon P; Windt, Gerritje J W van der; Eldering, Eric

T-cell dysfunction in CLL is mediated through expression of Siglec-10 ligands CD24 and CD52 on CLL cells

CLL 中的 T 细胞功能障碍是通过 CLL 细胞上 Siglec-10 配体 CD24 和 CD52 的表达介导的

Jaco A C van Bruggen, Fleur S Peters, Morris Mes, Joanne M Rietveld, Elisa Cerretani, Gaspard Cretenet, Roel van Kampen, Aldo Jongejan, Perry D Moerland, J Joseph Melenhorst, Gerritje J W van der Windt, Eric Eldering, Arnon P Kater

Metabolic signature and response to glutamine deprivation are independent of p53 status in B cell malignancies

B细胞恶性肿瘤中代谢特征和对谷氨酰胺缺乏的反应与p53状态无关

Chiara Montironi ,Zhenghao Chen ,Ingrid A M Derks ,Gaspard Cretenet ,Esmée A Krap ,Eric Eldering ,Helga Simon-Molas

Immunometabolism unveiled: Pioneering breakthroughs in cancer therapeutics

免疫代谢揭秘:癌症治疗领域的开创性突破

Eldering, Eric; Ricci, Jean-Ehrland